S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
PwC Australia sidelines 9 directors as leak of tax information investigated
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
Buy THIS stock before Taiwan is attacked (Ad)
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
PwC Australia sidelines 9 directors as leak of tax information investigated
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
Buy THIS stock before Taiwan is attacked (Ad)
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
PwC Australia sidelines 9 directors as leak of tax information investigated
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
Buy THIS stock before Taiwan is attacked (Ad)
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
PwC Australia sidelines 9 directors as leak of tax information investigated
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
Buy THIS stock before Taiwan is attacked (Ad)
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
OTCMKTS:EDTXF

Spectral Medical (EDTXF) Stock Forecast, Price & News

$0.25
0.00 (0.00%)
(As of 05/26/2023 ET)
Compare
Today's Range
$0.25
▼
$0.25
50-Day Range
$0.19
▼
$0.27
52-Week Range
$0.17
▼
$0.45
Volume
N/A
Average Volume
46,392 shs
Market Capitalization
$69.02 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsEarningsHeadlinesShort Interest

EDTXF stock logo

About Spectral Medical (OTCMKTS:EDTXF) Stock

Spectral Medical, Inc. engages in the development and commercialization of therapeutic treatment for septic shock. Its products include endotoxin activity assay diagnostic and polymyxin b-hemoperfusion therapeutic device. The company was founded on July 29, 1991 and is headquartered in Toronto, Canada.

Receive EDTXF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Spectral Medical and its competitors with MarketBeat's FREE daily newsletter.

EDTXF Stock News Headlines

May 12, 2023 | finance.yahoo.com
Spectral Medical Announces First Quarter Results and Provides Corporate Update
May 4, 2023 | finance.yahoo.com
Spectral Medical Inc. Announces Director Resignation
May 29, 2023 | Behind the Markets (Ad)
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
April 27, 2023 | theglobeandmail.com
Closing Bell: Spectral Medical Inc down on Wednesday (EDT)
April 20, 2023 | theglobeandmail.com
Closing Bell: Spectral Medical Inc flat on Wednesday (EDT)
April 6, 2023 | finance.yahoo.com
Spectral Medical Announces Investor Update Conference Call
March 24, 2023 | finance.yahoo.com
Spectral Medical Announces Fourth Quarter and Fiscal 2022 Results and Provides Corporate Update
March 9, 2023 | finance.yahoo.com
Spectral Medical Announces the Opening of Two Additional Tigris Clinical Trial Sites
May 29, 2023 | Behind the Markets (Ad)
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
February 22, 2023 | finanznachrichten.de
Spectral Medical Inc.: Spectral Medical To Present At Microcap Rodeo's Annual Winter Wonderland- Best Ideas Virtual Investor Conference Today
February 22, 2023 | finance.yahoo.com
Spectral Medical To Present At Microcap Rodeo's Annual Winter Wonderland- Best Ideas Virtual Investor Conference Today
February 12, 2023 | finance.yahoo.com
The past three years for Spectral Medical (TSE:EDT) investors has not been profitable
January 12, 2023 | finance.yahoo.com
Spectral Medical Provides Update on Tigris Clinical Trial and Other Business Developments
January 4, 2023 | bizjournals.com
$10M center would support additive manufacturing, product development
December 13, 2022 | finance.yahoo.com
Spectral Medical Announces Strategic Joint Venture With Infomed to Accelerate Commercialization of Dimi and Sami Dialysis Devices
October 5, 2022 | finance.yahoo.com
Spectral Medical Inc. Announces Proposed Public Offering of Units and Private Placement of Notes
September 5, 2022 | finance.yahoo.com
Spectral Medical (TSE:EDT) shareholders have earned a 32% return over the last year
July 26, 2022 | finance.yahoo.com
Is Spectral Medical (TSE:EDT) In A Good Position To Invest In Growth?
July 26, 2022 | finance.yahoo.com
Spectral Medical’s Chief Medical Officer, Dr. John Kellum, to be the Featured Speaker in Webinar Hosted by Sepsis Alliance
July 14, 2022 | finance.yahoo.com
Spectral Medical Highlights From Vicenza Course 2022
July 13, 2022 | financialpost.com
Spectral Medical to Participate at the Benzinga All Access event on July 15, 2022
May 14, 2022 | seekingalpha.com
Spectral Diagnostics GAAP EPS of -C$0.01, revenue of C$0.48M
March 24, 2022 | finance.yahoo.com
Spectral Announces Fourth Quarter and Fiscal 2021 Results and Corporate Update
March 21, 2022 | finance.yahoo.com
Spectral Medical Announces Appointment of Blair McInnis as CFO
February 11, 2022 | finance.yahoo.com
Spectral Medical Reports Progress on Tigris Clinical Trial
January 10, 2022 | finance.yahoo.com
Here's Why We're Watching Spectral Medical's (TSE:EDT) Cash Burn Situation
December 3, 2021 | finance.yahoo.com
Spectral to Present at the SNN Network Canada Virtual Event on Wednesday, December 8, 2021
See More Headlines
Receive EDTXF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Spectral Medical and its competitors with MarketBeat's FREE daily newsletter.

EDTXF Company Calendar

Last Earnings
3/24/2023
Today
5/29/2023
Next Earnings (Estimated)
8/10/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:EDTXF
Previous Symbol
OTCMKTS:DIAGF
CUSIP
N/A
CIK
N/A
Web
www.spectraldx.com
Phone
(416) 626-3233
Fax
416-626-7383
Employees
31
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-8,650,000.00
Net Margins
-666.31%
Pretax Margin
-679.51%
Return on Equity
-2,155.87%
Return on Assets
-149.64%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.97
Quick Ratio
0.73

Sales & Book Value

Annual Sales
$1.28 million
Price / Sales
53.93
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.01 per share
Price / Book
24.78

Miscellaneous

Outstanding Shares
278,550,000
Free Float
274,370,000
Market Cap
$69.02 million
Optionable
Not Optionable
Beta
0.66

Key Executives

  • Chris Seto
    Chief Executive Officer & Director
  • Blair McInnis
    Chief Financial Officer
  • Debra M. Foster
    Vice President-Clinical Development
  • John Kellum
    Chief Medical Officer

Key Competitors

View All Competitors













EDTXF Stock - Frequently Asked Questions

How have EDTXF shares performed in 2023?

Spectral Medical's stock was trading at $0.2681 at the beginning of the year. Since then, EDTXF shares have decreased by 7.6% and is now trading at $0.2478.
View the best growth stocks for 2023 here.

Are investors shorting Spectral Medical?

Spectral Medical saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 68,500 shares, a drop of 20.3% from the April 30th total of 86,000 shares. Based on an average trading volume of 21,000 shares, the days-to-cover ratio is presently 3.3 days.
View Spectral Medical's Short Interest.

When is Spectral Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023.
View our EDTXF earnings forecast.

How were Spectral Medical's earnings last quarter?

Spectral Medical Inc. (OTCMKTS:EDTXF) posted its quarterly earnings results on Friday, March, 24th. The company reported ($0.01) earnings per share for the quarter. The firm had revenue of $0.41 million for the quarter. Spectral Medical had a negative net margin of 666.31% and a negative trailing twelve-month return on equity of 2,155.87%.

What is Spectral Medical's stock symbol?

Spectral Medical trades on the OTCMKTS under the ticker symbol "EDTXF."

How do I buy shares of Spectral Medical?

Shares of EDTXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Spectral Medical's stock price today?

One share of EDTXF stock can currently be purchased for approximately $0.25.

How much money does Spectral Medical make?

Spectral Medical (OTCMKTS:EDTXF) has a market capitalization of $69.02 million and generates $1.28 million in revenue each year. The company earns $-8,650,000.00 in net income (profit) each year or ($0.04) on an earnings per share basis.

How can I contact Spectral Medical?

Spectral Medical's mailing address is 135 The West Mall Unit 2, Toronto A6, M9C 1C2. The official website for the company is www.spectraldx.com. The company can be reached via phone at (416) 626-3233, via email at am@spinnakercmi.com, or via fax at 416-626-7383.

This page (OTCMKTS:EDTXF) was last updated on 5/29/2023 by MarketBeat.com Staff

My Account -